Navigation Links
Mercy Medical Center First Hospital in Maryland to Utilize New FDA Approved Drug-Coated Balloon Catheter for Treatment of Arteriovenous Fistulas
Date:10/11/2017

Alain Tanbe, M.D., a fellowship-trained vascular surgeon at The Vascular Center at Mercy Medical Center, recently utilized the FDA-approved LUTONIX® 035 Drug Coated Balloon (DCB) Catheter 035 to treat arteriovenous (AV) fistula, Paul R. Lucas, M.D., Director of Mercy’s Vascular Center, announced. Dr. Tanbe was the first vascular surgeon in the Maryland to use the DCB catheter for use in an End Stage Renal Disease (ESRD) patient.

According to Dr. Lucas, arteriovenous (AV) fistulas are abnormal connections between an artery and a vein as may occur due to injury, congenital and genetic conditions, and surgery—the latter most often for use in dialysis in people with severe kidney disease.

“Patients with late stage kidney failure may undergo surgery to create an arteriovenous or AV fistula—the connection of an artery to a vein--to make it easier to perform dialysis. If a dialysis needle is placed into a vein too often, scarring may occur, causing blockages and narrowing of the blood vessel, thus leading to additional venous reinterventions--these are time-consuming and difficult for the patient. The use of the new drug-coated balloon catheter gives physicians another option,” Dr. Lucas said.

With the LUTONIX® drug-coated balloon catheter, ESRD patients undergo fewer interruptions of their treatment, spend less time undergoing access maintenance, leading to improved patient satisfaction and a better quality of life.

The use of angioplasty (using a balloon for unblocking of a blood vessel) balloon catheters to deliver drugs to treat damaged portions of an artery “have been explored for more than 20 years. Drug delivery sleeves fit over catheters, porous balloons that would allow the drug to weep into the vessel wall after inflation. The challenge has been finding a way to achieve delivery of a sufficiently therapeutic dose. The new DCB does just that, coated with the drug, Paclitaxel,” Dr. Lucas said.

“It’s the first and only drug coated balloon that is FDA approved as safe and effective in end stage renal disease patients with stenotic lesions in dialysis arteriovenous (AV) fistulae,” Dr. Tanbe noted.

“More than 2 million patients worldwide undergo dialysis treatments, with sessions lasting about four hours and required three times a week. The LUTONIX® DCB catheter offers vascular surgeons a great tool to address arterial stenosis (narrowing of the artery) and blockages. Recent research has shown that the number of reinterventions are significantly reduced, thanks to the DCB, and that means a lot less stress, less time spent in dialysis, and less discomfort for the patient,” Dr. Tanbe said.

The Vascular Center at Mercy Medical Center in Baltimore, Maryland, is led by Dr. Paul Lucas, Director of The Vascular Center and Chief of Vascular Surgery at Mercy. He is joined by vascular surgeons Dr. Kurtis Kim and Dr. Alain Tanbe, as well as a team of experienced technologists. Mercy’s Vascular Center offers comprehensive diagnosis and treatment of circulatory system disorders including stroke and mini stroke, leg pain and swelling, blood clots in veins, aneurysms, varicose veins and circulatory disease.

The LUTONIX® 035 DCB Catheter was developed by C. R. Bard, Inc. (http://www.crbard.com). Headquartered in Murray Hill, NJ, C.R. Bard, Inc., is a leading multinational developer, manufacturer and marketer of innovative, life-enhancing medical technologies in the fields of vascular, urology, oncology and surgical specialty products.

Mercy Medical Center is a 143-year-old, university-affiliated medical facility with a national reputation for women's health. For more information, visit Mercy online at http://www.mdmercy.com, MDMercyMedia on FACEBOOK and TWITTER, or call 1-800-MD-Mercy.

Read the full story at http://www.prweb.com/releases/2017/10/prweb14790541.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Mercy's Dr. Kevin Audlin First Physician in Mid-Atlantic Region to Use New Low-Impact Laparoscopic Surgery to Treat GYN Conditions
2. Mercy Medical Center Featured in National Documentary, "The Doctor Fix: A New Era of Modern Medicine"
3. Mercy Medical Center Earns Joint Commission Certification in Uterine & Ovarian Cancer
4. Give Something Back Donates $45,000 to Mercy College to Support Students of Incarcerated Parents
5. Mercy Medical Center Named to “America’s Best MidSize Employers” List for 2017 by Forbes Magazine
6. Mercy Medical Center in Baltimore, MD, Launches Awareness Campaign to Inform Community about Importance of Hepatitis C Screening
7. Children’s Mercy Kansas City Partners with Engage Mobile to Develop Pediatric Decision Support App - Results Presented in Silicon Valley
8. Mercy Medical Center To Serve as Title Sponsor for Baltimore Women's Classic 5K
9. SIU Dental Medicine Alums Spearhead Mission of Mercy in Collinsville
10. Mercy Medical Center’s Nursing Excellence Once Again Honored with Prestigious Magnet Recognition
11. US Sports Camps' Nike Pro Sports Baseball Camps Announces Lawrenceville School and Mercy College Locations for Summer 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/11/2019)... ... January 11, 2019 , ... ... endometriosis to remove inflammatory endometriosis tissue, relieve pain, and help restore fertility. , ... In more common cases, tissue typically grows on the ovaries, fallopian tubes, and ...
(Date:1/10/2019)... ... January 10, 2019 , ... Net-Translators, ... partnered with MD101, a regulatory consulting company that serves the medical industry. The ... servicing companies in the medical device and healthcare industries. Based in France, they ...
(Date:1/10/2019)... SAN DIEGO (PRWEB) , ... January 10, 2019 ... ... and education on CBD and Hemp companies, partners with NeuCana Companion to educate ... pet owners. , CBD is believed to help calm pain and anxiety related ...
(Date:1/8/2019)... ... January 08, 2019 , ... ... now have Norepinephrine in their patent-pending vial-based configuration, Snap-N-Go®, available to order ... are not commercially available) deliver a precise dose when introduced into a ...
(Date:1/7/2019)... ... January 07, 2019 , ... byte is thrilled ... to improve smiles and physical health across the nation. byte is an at-home ... a brighter and straighter smile being treated by leading orthodontists and the latest ...
Breaking Medicine News(10 mins):
(Date:1/10/2019)... ... January 10, 2019 , ... Mindray, a leading developer ... Delivery platform, providing a modular, state-of-the-art family of anesthesia solutions. The new ... its unwavering commitment to perioperative care. , “The recently launched Advantage platform ...
(Date:1/10/2019)... ... 10, 2019 , ... Pelican BioThermal , the global ... under the leadership of Dominic Hyde, vice president of Credo™ on Demand. , ... shipper rental program allowing organizations to choose the shipper application that best fits ...
(Date:1/8/2019)... , ... January 08, 2019 , ... ... been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. ... System and demonstrated a commitment to exemplary care for men suffering from symptoms ...
Breaking Medicine Technology: